YEEBO (INT'L H)(00259): Chen Guojie appointed as Executive Director
Yidu (International Holdings) (00259) announced that Mr. Liang Ziquan has informed the board that in order to spend more time with his family, he has decided not to stand for re-election as an executive director of the company at the annual general meeting of shareholders to be held on August 24, 2026. Therefore, he will no longer serve as an executive director after the conclusion of the annual general meeting of shareholders, effective from August 24, 2026.
YEEBO (INT'L H)(00259) announced that Mr. Liang Ziquan has informed the board that he has decided not to stand for re-election as an executive director of the company at the upcoming annual general meeting of shareholders to be held on August 24, 2026, in order to devote more time to his family. Therefore, he will no longer serve as an executive director after the conclusion of the annual general meeting, effective from August 24, 2026.
The board is pleased to announce the appointment of Mr. Chan Kwok Kit as an executive director, effective from August 24, 2026.
Related Articles
ZHONG JIA GX (00899) plans to offer a discount of approximately 12.5% on the placement of up to 29.677 million shares, with net proceeds of around HKD 3.95 million.
Luxshare Precision Industry (02475) announced its interim results, with net profit attributable to shareholders of approximately 7.843 billion yuan, a year-on-year increase of 18.04%.
Jiangsu Hengrui Pharmaceuticals (01276): The drug marketing authorization application for HRG2010 capsules has been accepted.
ZHONG JIA GX (00899) plans to offer a discount of approximately 12.5% on the placement of up to 29.677 million shares, with net proceeds of around HKD 3.95 million.
Luxshare Precision Industry (02475) announced its interim results, with net profit attributable to shareholders of approximately 7.843 billion yuan, a year-on-year increase of 18.04%.
Jiangsu Hengrui Pharmaceuticals (01276): The drug marketing authorization application for HRG2010 capsules has been accepted.
RECOMMEND
